{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:05:36Z","timestamp":1732043136905},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,13]]},"DOI":"10.7759\/cureus.48766","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T04:43:25Z","timestamp":1699937005000},"source":"Crossref","is-referenced-by-count":1,"title":["Navigating Vaccine Uncertainty: Anxiety and Fourth Dose Hesitancy Among Saudi Adults"],"prefix":"10.7759","author":[{"given":"Majed M","family":"Althomali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas S","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad M","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulelah M","family":"Alsalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M","family":"Alqhatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber M","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S","family":"Abdel-Moneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01696-3","article-title":"Delta coronavirus variant: scientists brace for impact","volume":"595","author":"Callaway E","year":"2021","unstructured":"Callaway E. Delta coronavirus variant: scientists brace for impact. Nature. 2021, 595:17-8. 10.1038\/d41586-021-01696-3","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz E","year":"2021","unstructured":"Volz E, Mishra S, Chand M, et al.. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021, 593:266-9. 10.1038\/s41586-021-03470-x","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2021.100054","article-title":"Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)","volume":"7","author":"Sanches PR","year":"2021","unstructured":"Sanches PR, Charlie-Silva I, Braz HL, Bittar C, Freitas Calmon M, Rahal P, Cilli EM. Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India). J Virus Erad. 2021, 7:100054. 10.1016\/j.jve.2021.100054","journal-title":"J Virus Erad"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria NR","year":"2021","unstructured":"Faria NR, Mellan TA, Whittaker C, et al.. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021, 372:815-21. 10.1126\/science.abh2644","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27524","article-title":"Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective","volume":"94","author":"Saxena SK","year":"2022","unstructured":"Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. J Med Virol. 2022, 94:1738-44. 10.1002\/jmv.27524","journal-title":"J Med Virol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang P","year":"2021","unstructured":"Wang P, Nair MS, Liu L, et al.. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021, 593:130-5. 10.1038\/s41586-021-03398-2","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran WF","year":"2021","unstructured":"Garcia-Beltran WF, Lam EC, St Denis K, et al.. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021, 184:2372-83.e9. 10.1016\/j.cell.2021.03.013","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.03.055","article-title":"Antibody evasion by the P.1 strain of SARS-CoV-2","volume":"184","author":"Dejnirattisai W","year":"2021","unstructured":"Dejnirattisai W, Zhou D, Supasa P, et al.. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021, 184:2939-54.e9. 10.1016\/j.cell.2021.03.055","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2151381","article-title":"Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination","volume":"12","author":"Wang M","year":"2023","unstructured":"Wang M, Zhou B, Fan Q, et al.. Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination. Emerg Microbes Infect. 2023, 12:2151381. 10.1080\/22221751.2022.2151381","journal-title":"Emerg Microbes Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27697","article-title":"Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review","volume":"94","author":"Chenchula S","year":"2022","unstructured":"Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J Med Virol. 2022, 94:2969-76. 10.1002\/jmv.27697","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2062983","article-title":"Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review","volume":"18","author":"Du Y","year":"2022","unstructured":"Du Y, Chen L, Shi Y. Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review. Hum Vaccin Immunother. 2022, 18:2062983. 10.1080\/21645515.2022.2062983","journal-title":"Hum Vaccin Immunother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7107e2","article-title":"Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 States, August 2021-January 2022","volume":"71","author":"Ferdinands JM","year":"2022","unstructured":"Ferdinands JM, Rao S, Dixon BE, et al.. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:255-63. 10.15585\/mmwr.mm7107e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","unstructured":"Coronavirus (COVID-19) update. FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. (2022). Accessed: June 6, 2023: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-tw...."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01832-0","article-title":"Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60\u2009years","volume":"28","author":"Arbel R","year":"2022","unstructured":"Arbel R, Sergienko R, Friger M, et al.. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60\u2009years. Nat Med. 2022, 28:1486-90. 10.1038\/s41591-022-01832-0","journal-title":"Nat Med"},{"key":"ref15","unstructured":"Request for vaccine approval in the Kingdom. (2022). Accessed. September 15, 2023: https:\/\/www.moh.gov.sa\/en\/eServices\/Pages\/Covid19-egistration.aspx."},{"key":"ref16","unstructured":"WHO coronavirus (COVID-19) dashboard. (2023). Accessed. April 13, 2023: https:\/\/covid19.who.int\/region\/emro\/country\/sa."},{"key":"ref17","unstructured":"ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines. (2023). Accessed. April 6, 2023: https:\/\/www.ema.europa.eu\/en\/news\/ecdc-ema-issue-advice-fourth-doses-mrna-covid-19-vaccines."},{"key":"ref18","unstructured":"Sample size calculator. (2023). Accessed. June 10, 2023: http:\/\/www.raosoft.com\/samplesize.html."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer RL","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166:1092-7. 10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"ref20","unstructured":"Spitzer RL. GAD-7 calculator. 2006\/05\/24 edition. (2022). Accessed: September 22, 2023: https:\/\/www.mdcalc.com\/calc\/1727\/gad7-general-anxiety-disorder7."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03677-2","article-title":"Primary emotions as predictors for fear of COVID-19 in former inpatients with major depressive disorder and healthy control participants","volume":"22","author":"Sanwald S","year":"2022","unstructured":"Sanwald S, Widenhorn-M\u00fcller K, Montag C, Kiefer M. Primary emotions as predictors for fear of COVID-19 in former inpatients with major depressive disorder and healthy control participants. BMC Psychiatry. 2022, 22:94. 10.1186\/s12888-021-03677-2","journal-title":"BMC Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.028","article-title":"A longitudinal study on the mental health of general population during the COVID-19 epidemic in China","volume":"87","author":"Wang C","year":"2020","unstructured":"Wang C, Pan R, Wan X, et al.. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020, 87:40-8. 10.1016\/j.bbi.2020.04.028","journal-title":"Brain Behav Immun"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-020-00477-9","article-title":"Fear of COVID-19 and depression: a comparative study among the general population and healthcare professionals during COVID-19 pandemic crisis in Bangladesh","volume":"21","author":"Sakib N","year":"2023","unstructured":"Sakib N, Akter T, Zohra F, Bhuiyan AK, Mamun MA, Griffiths MD. Fear of COVID-19 and depression: a comparative study among the general population and healthcare professionals during COVID-19 pandemic crisis in Bangladesh. Int J Ment Health Addict. 2023, 21:976-92. 10.1007\/s11469-020-00477-9","journal-title":"Int J Ment Health Addict"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2022.13","article-title":"Neuropsychiatric symptoms in post-COVID-19 long haulers","volume":"34","author":"Alghamdi HY","year":"2022","unstructured":"Alghamdi HY, Alrashed AM, Jawhari AM, Abdel-Moneim AS. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022, 34:318-29. 10.1017\/neu.2022.13","journal-title":"Acta Neuropsychiatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0020764020915212","article-title":"The outbreak of COVID-19 coronavirus and its impact on global mental health","volume":"66","author":"Torales J","year":"2020","unstructured":"Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020, 66:317-20. 10.1177\/0020764020915212","journal-title":"Int J Soc Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.708965","article-title":"Gender differences in anxiety among COVID-19 inpatients under isolation: a questionnaire survey during the first and second waves of the COVID-19 pandemic in Japan","volume":"9","author":"Tsukamoto R","year":"2021","unstructured":"Tsukamoto R, Kataoka Y, Mino K, Ishibashi N, Shibata M, Matsuo H, Fujiwara H. Gender differences in anxiety among COVID-19 inpatients under isolation: a questionnaire survey during the first and second waves of the COVID-19 pandemic in Japan. Front Public Health. 2021, 9:708965. 10.3389\/fpubh.2021.708965","journal-title":"Front Public Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7326\/M20-3569","article-title":"Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults","volume":"173","author":"Fisher KA","year":"2020","unstructured":"Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults. Ann Intern Med. 2020, 173:964-73. 10.7326\/M20-3569","journal-title":"Ann Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006e3","article-title":"COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination - United States, September and December 2020","volume":"70","author":"Nguyen KH","year":"2021","unstructured":"Nguyen KH, Srivastav A, Razzaghi H, et al.. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination - United States, September and December 2020. MMWR Morb Mortal Wkly Rep. 2021, 70:217-22. 10.15585\/mmwr.mm7006e3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040737","article-title":"Investigating the reasons for receiving the second booster dose of the COVID-19 vaccine in adults and in people with chronic medical conditions in Southern Italy","volume":"11","author":"Miraglia Del Giudice G","year":"2023","unstructured":"Miraglia Del Giudice G, Folcarelli L, Della Polla G, Napoli A, Angelillo IF. Investigating the reasons for receiving the second booster dose of the COVID-19 vaccine in adults and in people with chronic medical conditions in Southern Italy. Vaccines (Basel). 2023, 11:737. 10.3390\/vaccines11040737","journal-title":"Vaccines (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121461","article-title":"Public perceptions and acceptance of COVID-19 booster vaccination in china: a cross-sectional study","volume":"9","author":"Lai X","year":"2021","unstructured":"Lai X, Zhu H, Wang J, et al.. Public perceptions and acceptance of COVID-19 booster vaccination in china: a cross-sectional study. Vaccines (Basel). 2021, 9:1461. 10.3390\/vaccines9121461","journal-title":"Vaccines (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1316-7","article-title":"Relationship between meaning in life and death anxiety in the elderly: self-esteem as a mediator","volume":"19","author":"Zhang J","year":"2019","unstructured":"Zhang J, Peng J, Gao P, Huang H, Cao Y, Zheng L, Miao D. Relationship between meaning in life and death anxiety in the elderly: self-esteem as a mediator. BMC Geriatr. 2019, 19:308. 10.1186\/s12877-019-1316-7","journal-title":"BMC Geriatr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720005188","article-title":"COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II","volume":"52","author":"Freeman D","year":"2022","unstructured":"Freeman D, Loe BS, Chadwick A, et al.. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2022, 52:3127-41. 10.1017\/S0033291720005188","journal-title":"Psychol Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.041","article-title":"Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic","volume":"38","author":"Detoc M","year":"2020","unstructured":"Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020, 38:7002-6. 10.1016\/j.vaccine.2020.09.041","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100495","article-title":"Determinants of COVID-19 vaccine acceptance in the US","volume":"26","author":"Malik AA","year":"2020","unstructured":"Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020, 26:100495. 10.1016\/j.eclinm.2020.100495","journal-title":"EClinicalMedicine"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27825","article-title":"Acceptance of COVID-19 booster vaccination based on the protection motivation theory: a cross-sectional study\u00a0in China","volume":"94","author":"Wu F","year":"2022","unstructured":"Wu F, Yuan Y, Deng Z, et al.. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: a cross-sectional study\u00a0in China. J Med Virol. 2022, 94:4115-24. 10.1002\/jmv.27825","journal-title":"J Med Virol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/10911359.2022.2046235","article-title":"Willingness to receive COVID-19 vaccine booster doses for adults and their children in Vietnam","author":"Chu D-T","year":"2022","unstructured":"Chu D-T, Vu Thi H, Nguyen Thi YV, et al.. Willingness to receive COVID-19 vaccine booster doses for adults and their children in Vietnam. J Human Behav Social Environ. 2022, 1-13. 10.1080\/10911359.2022.2046235","journal-title":"J Human Behav Social Environ"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030425","article-title":"Willingness to take the booster vaccine in a nationally representative sample of Danes","volume":"10","author":"J\u00f8rgensen FJ","year":"2022","unstructured":"J\u00f8rgensen FJ, Nielsen LH, Petersen MB. Willingness to take the booster vaccine in a nationally representative sample of Danes. Vaccines (Basel). 2022, 10:425. 10.3390\/vaccines10030425","journal-title":"Vaccines (Basel)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030410","article-title":"Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study","volume":"10","author":"Al-Qerem W","year":"2022","unstructured":"Al-Qerem W, Al Bawab AQ, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines (Basel). 2022, 10:410. 10.3390\/vaccines10030410","journal-title":"Vaccines (Basel)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030191","article-title":"The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study","volume":"9","author":"Wang J","year":"2021","unstructured":"Wang J, Lu X, Lai X, et al.. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study. Vaccines (Basel). 2021, 9:191. 10.3390\/vaccines9030191","journal-title":"Vaccines (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030638","article-title":"COVID-19 vaccine booster hesitancy in Malaysia: a web-based cross-sectional study","volume":"11","author":"Lee KW","year":"2023","unstructured":"Lee KW, Yap SF, Ong HT, Oo M, Swe KM. COVID-19 vaccine booster hesitancy in Malaysia: a web-based cross-sectional study. Vaccines (Basel). 2023, 11:638. 10.3390\/vaccines11030638","journal-title":"Vaccines (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063338","article-title":"Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination","volume":"23","author":"Yamada S","year":"2022","unstructured":"Yamada S, Asakura H. Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination. Int J Mol Sci. 2022, 23:3338. 10.3390\/ijms23063338","journal-title":"Int J Mol Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202102_24877","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines","volume":"25","author":"Meo SA","year":"2021","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021, 25:1663-9. 10.26355\/eurrev_202102_24877","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.760047","article-title":"BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees","volume":"8","author":"Alghamdi AN","year":"2021","unstructured":"Alghamdi AN, Alotaibi MI, Alqahtani AS, Al Aboud D, Abdel-Moneim AS. BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees. Front Med (Lausanne). 2021, 8:760047. 10.3389\/fmed.2021.760047","journal-title":"Front Med (Lausanne)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107970","article-title":"Autoimmune phenomena following SARS-CoV-2 vaccination","volume":"99","author":"Ishay Y","year":"2021","unstructured":"Ishay Y, Kenig A, Tsemach-Toren T, Amer R, Rubin L, Hershkovitz Y, Kharouf F. Autoimmune phenomena following SARS-CoV-2 vaccination. Int Immunopharmacol. 2021, 99:107970. 10.1016\/j.intimp.2021.107970","journal-title":"Int Immunopharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet T","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022, 28:202-21. 10.1016\/j.cmi.2021.10.005","journal-title":"Clin Microbiol Infect"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.057","article-title":"Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020","volume":"39","author":"Lytle KL","year":"2021","unstructured":"Lytle KL, Collins SP, Feldstein LR, et al.. Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020. Vaccine. 2021, 39:5271-6. 10.1016\/j.vaccine.2021.07.057","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.06.074","article-title":"Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US","volume":"38","author":"Szilagyi PG","year":"2020","unstructured":"Szilagyi PG, Albertin CS, Gurfinkel D, et al.. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020, 38:6027-37. 10.1016\/j.vaccine.2020.06.074","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.057","article-title":"Multi-domain narrative review of vaccine hesitancy in childhood","volume":"39","author":"Hasnan S","year":"2021","unstructured":"Hasnan S, Tan NC. Multi-domain narrative review of vaccine hesitancy in childhood. Vaccine. 2021, 39:1910-20. 10.1016\/j.vaccine.2021.02.057","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28596","article-title":"What are the factors that contribute to parental vaccine-hesitancy and what can we do about it?","volume":"10","author":"Williams SE","year":"2014","unstructured":"Williams SE. What are the factors that contribute to parental vaccine-hesitancy and what can we do about it?. Hum Vaccin Immunother. 2014, 10:2584-96. 10.4161\/hv.28596","journal-title":"Hum Vaccin Immunother"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.035","article-title":"Vaccine hesitancy: causes, consequences, and a call to action","volume":"33 Suppl 4","author":"Salmon DA","year":"2015","unstructured":"Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: causes, consequences, and a call to action. Vaccine. 2015, 33 Suppl 4:D66-71. 10.1016\/j.vaccine.2015.09.035","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16122070","article-title":"Knowledge, attitudes, and behaviors of parents towards recommended adult vaccinations: an explanatory survey in the geographic area of Naples, Italy","volume":"16","author":"Napolitano F","year":"2019","unstructured":"Napolitano F, Della Polla G, Angelillo IF. Knowledge, attitudes, and behaviors of parents towards recommended adult vaccinations: an explanatory survey in the geographic area of Naples, Italy. Int J Environ Res Public Health. 2019, 16:2070. 10.3390\/ijerph16122070","journal-title":"Int J Environ Res Public Health"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040560","article-title":"Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy","volume":"8","author":"Napolitano F","year":"2020","unstructured":"Napolitano F, Della Polla G, Capano MS, Augimeri M, Angelillo IF. Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy. Vaccines (Basel). 2020, 8:560. 10.3390\/vaccines8040560","journal-title":"Vaccines (Basel)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.943876","article-title":"The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: a cross-sectional study in central China","volume":"10","author":"Qin W","year":"2022","unstructured":"Qin W, Zhang X, Wang Y, et al.. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: a cross-sectional study in central China. Front Public Health. 2022, 10:943876. 10.3389\/fpubh.2022.943876","journal-title":"Front Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/203080-navigating-vaccine-uncertainty-anxiety-and-fourth-dose-hesitancy-among-saudi-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:44Z","timestamp":1707509384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/203080-navigating-vaccine-uncertainty-anxiety-and-fourth-dose-hesitancy-among-saudi-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.48766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,13]]}}}